Logo image of SARO

STANDARDAERO INC (SARO) Stock Fundamental Analysis

NYSE:SARO - US85423L1035 - Common Stock

26.55 USD
-0.93 (-3.38%)
Last: 9/5/2025, 7:00:00 PM
26.55 USD
0 (0%)
After Hours: 9/5/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, SARO scores 4 out of 10 in our fundamental rating. SARO was compared to 69 industry peers in the Aerospace & Defense industry. There are concerns on the financial health of SARO while its profitability can be described as average. SARO is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

SARO had positive earnings in the past year.
SARO had a positive operating cash flow in the past year.
SARO Yearly Net Income VS EBIT VS OCF VS FCFSARO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

SARO has a Return On Assets (2.05%) which is comparable to the rest of the industry.
With a Return On Equity value of 5.29%, SARO perfoms like the industry average, outperforming 52.17% of the companies in the same industry.
SARO has a Return On Invested Capital of 6.97%. This is in the better half of the industry: SARO outperforms 62.32% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SARO is below the industry average of 8.22%.
The 3 year average ROIC (5.55%) for SARO is below the current ROIC(6.97%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.05%
ROE 5.29%
ROIC 6.97%
ROA(3y)-0.27%
ROA(5y)N/A
ROE(3y)-1.45%
ROE(5y)N/A
ROIC(3y)5.55%
ROIC(5y)N/A
SARO Yearly ROA, ROE, ROICSARO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 2 -2 4 6

1.3 Margins

With a Profit Margin value of 2.37%, SARO perfoms like the industry average, outperforming 49.28% of the companies in the same industry.
With a Operating Margin value of 8.16%, SARO perfoms like the industry average, outperforming 53.62% of the companies in the same industry.
In the last couple of years the Operating Margin of SARO has grown nicely.
SARO's Gross Margin of 14.90% is on the low side compared to the rest of the industry. SARO is outperformed by 75.36% of its industry peers.
In the last couple of years the Gross Margin of SARO has grown nicely.
Industry RankSector Rank
OM 8.16%
PM (TTM) 2.37%
GM 14.9%
OM growth 3Y17.41%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.43%
GM growth 5YN/A
SARO Yearly Profit, Operating, Gross MarginsSARO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 5 10

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SARO is destroying value.
The number of shares outstanding for SARO remains at a similar level compared to 1 year ago.
The debt/assets ratio for SARO has been reduced compared to a year ago.
SARO Yearly Shares OutstandingSARO Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 100M 200M 300M
SARO Yearly Total Debt VS Total AssetsSARO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 2.45 indicates that SARO is not a great score, but indicates only limited risk for bankruptcy at the moment.
SARO has a worse Altman-Z score (2.45) than 60.87% of its industry peers.
SARO has a Debt/Equity ratio of 0.91. This is a neutral value indicating SARO is somewhat dependend on debt financing.
SARO has a worse Debt to Equity ratio (0.91) than 73.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Altman-Z 2.45
ROIC/WACC0.67
WACC10.4%
SARO Yearly LT Debt VS Equity VS FCFSARO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

SARO has a Current Ratio of 2.15. This indicates that SARO is financially healthy and has no problem in meeting its short term obligations.
SARO has a Current ratio (2.15) which is comparable to the rest of the industry.
A Quick Ratio of 1.49 indicates that SARO should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.49, SARO perfoms like the industry average, outperforming 52.17% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 1.49
SARO Yearly Current Assets VS Current LiabilitesSARO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1452.33% over the past year.
Looking at the last year, SARO shows a quite strong growth in Revenue. The Revenue has grown by 16.09% in the last year.
SARO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.60% yearly.
EPS 1Y (TTM)1452.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%913%
Revenue 1Y (TTM)16.09%
Revenue growth 3Y14.6%
Revenue growth 5YN/A
Sales Q2Q%13.49%

3.2 Future

Based on estimates for the next years, SARO will show a very strong growth in Earnings Per Share. The EPS will grow by 64.53% on average per year.
SARO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.13% yearly.
EPS Next Y176.53%
EPS Next 2Y89.79%
EPS Next 3Y64.53%
EPS Next 5YN/A
Revenue Next Year15.13%
Revenue Next 2Y13.15%
Revenue Next 3Y12.13%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
SARO Yearly Revenue VS EstimatesSARO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
SARO Yearly EPS VS EstimatesSARO Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0.5 1

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 34.93, SARO can be considered very expensive at the moment.
Based on the Price/Earnings ratio, SARO is valued a bit cheaper than the industry average as 65.22% of the companies are valued more expensively.
SARO's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.06.
SARO is valuated rather expensively with a Price/Forward Earnings ratio of 22.12.
71.01% of the companies in the same industry are more expensive than SARO, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.69, SARO is valued at the same level.
Industry RankSector Rank
PE 34.93
Fwd PE 22.12
SARO Price Earnings VS Forward Price EarningsSARO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SARO indicates a somewhat cheap valuation: SARO is cheaper than 72.46% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.57
SARO Per share dataSARO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

SARO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SARO's earnings are expected to grow with 64.53% in the coming years.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y89.79%
EPS Next 3Y64.53%

0

5. Dividend

5.1 Amount

SARO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

STANDARDAERO INC

NYSE:SARO (9/5/2025, 7:00:00 PM)

After market: 26.55 0 (0%)

26.55

-0.93 (-3.38%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-11 2025-11-11
Inst Owners52.81%
Inst Owner Change18.57%
Ins Owners0.45%
Ins Owner Change1.19%
Market Cap8.88B
Analysts81.33
Price Target36.72 (38.31%)
Short Float %3.23%
Short Ratio2.77
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.64%
Min EPS beat(2)6.56%
Max EPS beat(2)30.72%
EPS beat(4)4
Avg EPS beat(4)33.39%
Min EPS beat(4)6.56%
Max EPS beat(4)87.55%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.64%
Min Revenue beat(2)0.26%
Max Revenue beat(2)5.02%
Revenue beat(4)3
Avg Revenue beat(4)1.46%
Min Revenue beat(4)-0.43%
Max Revenue beat(4)5.02%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.86%
PT rev (3m)9.09%
EPS NQ rev (1m)2.33%
EPS NQ rev (3m)4.76%
EPS NY rev (1m)6.27%
EPS NY rev (3m)5.19%
Revenue NQ rev (1m)0.35%
Revenue NQ rev (3m)-0.75%
Revenue NY rev (1m)0.78%
Revenue NY rev (3m)0.84%
Valuation
Industry RankSector Rank
PE 34.93
Fwd PE 22.12
P/S 1.58
P/FCF N/A
P/OCF 121.01
P/B 3.53
P/tB N/A
EV/EBITDA 17.57
EPS(TTM)0.76
EY2.86%
EPS(NY)1.2
Fwd EY4.52%
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)0.22
OCFY0.83%
SpS16.8
BVpS7.51
TBVpS-1.2
PEG (NY)0.2
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.05%
ROE 5.29%
ROCE 8.82%
ROIC 6.97%
ROICexc 7.09%
ROICexgc 16.54%
OM 8.16%
PM (TTM) 2.37%
GM 14.9%
FCFM N/A
ROA(3y)-0.27%
ROA(5y)N/A
ROE(3y)-1.45%
ROE(5y)N/A
ROIC(3y)5.55%
ROIC(5y)N/A
ROICexc(3y)5.66%
ROICexc(5y)N/A
ROICexgc(3y)15.32%
ROICexgc(5y)N/A
ROCE(3y)7.03%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y17.41%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.43%
GM growth 5YN/A
F-Score6
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Debt/EBITDA 3.53
Cap/Depr 81.04%
Cap/Sales 2.76%
Interest Coverage 250
Cash Conversion 11.29%
Profit Quality N/A
Current Ratio 2.15
Quick Ratio 1.49
Altman-Z 2.45
F-Score6
WACC10.4%
ROIC/WACC0.67
Cap/Depr(3y)43.93%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.76%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1452.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%913%
EPS Next Y176.53%
EPS Next 2Y89.79%
EPS Next 3Y64.53%
EPS Next 5YN/A
Revenue 1Y (TTM)16.09%
Revenue growth 3Y14.6%
Revenue growth 5YN/A
Sales Q2Q%13.49%
Revenue Next Year15.13%
Revenue Next 2Y13.15%
Revenue Next 3Y12.13%
Revenue Next 5YN/A
EBIT growth 1Y25.53%
EBIT growth 3Y34.55%
EBIT growth 5YN/A
EBIT Next Year85.48%
EBIT Next 3Y33.89%
EBIT Next 5YN/A
FCF growth 1Y-169.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.43%
OCF growth 3Y-16.42%
OCF growth 5YN/A